What You Should Know:
- Health tech startup Ultrahuman has raised $17.5 million in Series B funding as it sets out to re-invent fitness-tech via its glucose tracking wearable that helps people improve their diet and exercise. The series B funding came from Alpha Wave Incubation (AWI), which is backed by DisruptAD and managed by Falcon Edge, Steadview Capital, Nexus Venture Partners, Blume Ventures, and Utsav Somani’s iSeed fund.
- Founded in 2020 by Mohit Kumar and Vatsal Singhal who were
Read More
Continuous Glucose Monitors (CGM)
Medtronic Receives FDA Approval for New Arm Indication for Continuous Glucose Monitoring System
Medtronic today announced that the FDA has approved a new arm indication for the Guardian Sensor 3, the company’s most accurate continuous glucose monitoring system and the only sensor approved in the U.S. to help control automated insulin delivery for patient with diabetes via its hybrid closed loop system – the MiniMed 670G system.This expanded indication will enable patients to wear the sensor on the upper arm, providing improved flexibility, enhanced performance for users, as well as
Read More
Medtronic Integrates With Fitbit to Understand How Exercise Impacts Glucose Levels
Medtronic has announced a partnership with connected health provider Fitbit to integrate health and activity tracking to physicians and care teams for patients living with diabetes. With this integration, patients with Type 2 diabetes will be able to monitor their glucose levels and physical activity data via Medtronic's iPro(TM)2 myLog mobile app. Together, the partnership will provide meaningful insight on how exercise impacts glucose levels for more effective diabetes care
Read More
